Our study indicated that TGF-β exhibited an inhibitory effect on SDH expression in osteosarcoma cells, thereby exhibiting a central function in tumor metabolism rerouting and subsequent drug resistance. This evidence concerns the gene TGFB1 and osteosarcoma.